SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-18-004222
Filing Date
2018-03-09
Accepted
2018-03-08 17:43:33
Documents
98
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K acrx20171231_10k.htm 10-K 2492987
2 EXHIBIT 10.20 ex_106745.htm EX-10.20 9676
3 EXHIBIT 21.2 ex_106677.htm EX-21.2 1859
4 EXHIBIT 23.1 ex_106678.htm EX-23.1 7533
5 EXHIBIT 31.1 ex_106679.htm EX-31.1 10223
6 EXHIBIT 31.2 ex_106680.htm EX-31.2 10272
7 EXHIBIT 32.1 ex_106681.htm EX-32.1 6974
14 f2.jpg GRAPHIC 45188
15 e1.jpg GRAPHIC 29856
16 img03.jpg GRAPHIC 16820
17 img02.jpg GRAPHIC 26317
18 b1.jpg GRAPHIC 12572
  Complete submission text file 0001437749-18-004222.txt   9586397

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT acrx-20171231.xml EX-101.INS 1840579
9 XBRL TAXONOMY EXTENSION SCHEMA acrx-20171231.xsd EX-101.SCH 90995
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20171231_cal.xml EX-101.CAL 62093
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20171231_def.xml EX-101.DEF 575027
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20171231_lab.xml EX-101.LAB 502370
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20171231_pre.xml EX-101.PRE 609305
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35068 | Film No.: 18677620
SIC: 2834 Pharmaceutical Preparations